Pharmagreen Biotech Inc. (PHBI)
OTHER OTC:PHBI
US Market
Holding PHBI?
Track your performance easily

Pharmagreen Biotech (PHBI) Income Statement

54 Followers

Pharmagreen Biotech Income Statement

Last quarter (Q4 2023), Pharmagreen Biotech's total revenue was $1.24K, an increase of Infinity% from the same quarter last year. In Q4, Pharmagreen Biotech's net income was $-144.85K. See Pharmagreen Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Sep 23Sep 22Sep 21Sep 20Sep 19
Total Revenue
$ 4.23K$ 3.00K--$ -224.69K-
Cost of Revenue
$ 2.55K$ 2.07K----
Gross Profit
$ 1.69K$ 930.00--$ -224.69K-
Operating Expense
$ 366.99K$ 474.94K$ 1.07M$ 752.73K$ 485.75K$ 648.32K
Operating Income
$ -365.30K$ -474.01K$ -1.07M$ -752.73K$ -485.75K$ -648.32K
Net Non Operating Interest Income Expense
$ -56.06K$ -55.87K$ -47.24K$ 768.98K$ 672.27K$ 126.63K
Other Income Expense
$ 260.56K$ 42.90K$ -273.23K$ -3.01M$ -1.32M$ 6.14K
Pretax Income
$ -674.28K$ -568.80K$ -812.01K$ -4.53M$ -2.48M$ -768.81K
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -674.25K$ -568.77K$ -811.99K$ -4.53M$ -2.44M$ -767.54K
Basic EPS
---$ -0.02$ -0.03$ -0.01
Diluted EPS
---$ -0.02$ -0.03$ -0.01
Basic Average Shares
$ 2.07B$ 466.53M$ 403.73M$ 293.71M$ 82.07M$ 74.06M
Diluted Average Shares
$ 2.07B$ 466.53M$ 403.73M$ 293.71M$ 82.07M$ 74.06M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 369.54K$ 477.01K-$ -752.73K$ -485.75K$ -648.32K
Net Income From Continuing And Discontinued Operation
$ -674.25K$ -568.77K$ -811.99K$ -4.53M$ -2.44M$ -767.54K
Normalized Income
$ -532.53K$ -418.07K$ -596.83K$ -3.57M$ -1.36M$ -565.08K
Interest Expense
------
EBIT
$ -618.22K$ -512.93K$ -764.77K$ -3.76M$ -1.81M$ -763.73K
EBITDA
$ -618.22K$ -512.93K$ -764.77K$ -3.76M$ -1.81M$ -763.73K
Currency in USD

Pharmagreen Biotech Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis